Most antigen-specific peripheral murine T lymphocytes express the T cell differentiation antigens, CD4 or CD8, and a TCR composed ofa CD3-associated disulfidelinked heterodimer, TCR-a/(3 (1, 2). However, recent studies have identified a distinct population of CD3+,CD4-,CD8-cells that appear early in thymic ontogeny and are maintained in the mature thymus and the peripheral lymphoid organs throughout adult life (3-5). Immunoprecipitation studies of murine CD3 +,CD4-, CD8-T cells have shown that the majority of these cells do not express cell surface TCR a/a; rather their TCR complex includes a 45-kD S glycoprotein disulfide linked to either the TCRV y/Cylt gene product or the TCRV y/Cy4 gene product (demonstrated by immunoprecipitation with anti TCRy antisera) (5-7). These results suggested that the TCR-, y/8' cells may compose a separate lineage that develops in the thymus before the TCRa/R-expressing T cells (7).
andJS have been described (19, 20) . These structural similarities, as well as the presence of TCR-y/8-bearing T cells in the thymus, raise the possibility that TCRy/S cells may also recognize MHC antigens . To address this question, we have generated alloreactive CD3 +,CD4 -,CD8 -TCRy/S cell lines and clones. One such TCR y/S cytolytic T cell (CTL) line was shown to recognize an MHC-linked antigen (21) . The present studies were undertaken to examine the nature ofthe MHC-linked ligand of the TCRy/S CTL line and clones and to analyze the biochemical and molecular nature of the TCR proteins expressed on the cell surface. We have also developed additional MHC-specific TCRy/S CTL in order to begin to explore the diversity of receptor expression and the MHC molecule recognition by this T cell subset .
Materials and Methods
Animals . BALB/c and C57BL/10 (1110) nu/nu mice, 2-10 mo old, were purchased from the Frederick Animal Research Facility (Frederick, MD). All other inbred and congeneic mice were purchased from The Jackson Laboratory (Bar Harbor, ME) or were bred in our own colony (National Institutes of Health, Bethesda, MD).
Monoclonal Antibodies and Antisera. The mAb 145-2C11, specific for the CD3-s chain of the TCR complex, was derived in our laboratory (22) . The anti-C yl/Cy2 and anti-C,4 antisera were generated by injecting rabbits with synthetic peptides derived from published gene sequences as previously described (3, 5) .
T Cell Lines and Clones. The derivation and propagation of the MHC-specific CD3', CD4-,CD8 -T cell lines has been described (21) . Clones were derived from the lines by limiting dilution . Briefly, 2 d after stimulation, activated T cells were added to individual wells of 96-well flat-bottomed microtiter plates at 0.5 cells/well in the presence of 100 U/ml human rIL-2 (Lot LP315; Cetus Corp., Emeryville, CA ; reference 23) and 5 x 10 5 irradiated (3,000 rad) allogeneic spleen cells. After 1-2 wk, cells from positive wells were transferred to 24-well plates with additional IL-2 and irradiated allogeneic stimulator cells. Thereafter the cloned cells were propagated in the same fashion as the T cell lines. CD3',CD4-,CD8 -bulk TCRy/S T cells were derived as described elsewhere (5) . Erythrocyte-depleted, freshly isolated BALB/c splenocytes were suspended in complete medium (RPMI 1640 supplemented with glutamine, 10% FCS, 2-ME (5 x 10 -5 M), Hepes buffer, and nutrient mix [sodium pyruvate, nonessential amino acids, glutamine, penicillin, streptomycin ; NIH media unit]) at 107 cells/ml. Cells were incubated with anti-Lyt-2 .2 (83-12-5, reference 24) and anti-L3T4 (RL 172.4, reference 25) mAb culture supernatants, each at a final concentration of 25%, for 30 min at room temperature . Cells were washed in complete medium and resuspended at 10 7 cells/ml in complete medium containing a preselected concentration of rabbit sera (as a source of complement). The cells were incubated for 30 min at 37°C and were washed again. Dead cells were removed by centrifugation on a Ficoll-Hypaque gradient (Lymphocyte M; Cedarlane Laboratories Ltd., Ontario, Canada). Viable cells were cultured for 2 d in the presence of anti-CD3 mAb followed by 3 d in IL-2-containing Con A-induced culture supernatants .
Lymphokine Assays. The secretion of soluble lymphokines was monitored by the ability of culture supernatants of activated T cells (collected after 24 h of incubation) to support the growth of the lymphokine-dependent HT-2 cell line (kindly provided by Dr. Richard Hodes, NIH) . 5 x 103 HT-2 cells were cultured for 24-36 h with the supernatants to be assayed, then pulsed for 16 h with 1 gCi of [3H]thymidine. IFN-y was assayed as previously described using an ELISA method (26) .
Biochemical Analysis . Cultured alloreactive T cells were 1251 surface labeled by the lactoperoxidase method (3) and lysed in 1% digitonin buffer for anti-CD3 and anti-C y4 immunoprecipitations, or in 0.5% NP-40 lysis buffer for anti-C yl/Cy2 precipitations as described (5). Lysates were precleared overnight at 4°C with protein A agarose beads and rabbit anti-eosin (coupled to KLH) antiserum (a kind gift from Dr. Pierre Henkart, NIH) . Precleared lysates were immunoprecipitated with 50 ul of anti-CD3 culture supernatant or 20 wl of rabbit anti TCR antisera and were analyzed by SDS-PAGE as described (3) . Proteins were visual-ized by drying the gels and developing with Kodak XAR 5 film in cassettes containing Lightning Plus developing screens (DuPont Co., Wilmington, DE), stored at -70°C . Approximate molecular weights of proteins were determined by comparison to Bethesda Research Laboratories (Gaithersburg, MD) or Amersham Corp. (Arlington Heights, IL) prestained high molecular weight standard markers that were electrophoresed in the same gels. N-glycosidase treatment and reduction/alkylation procedures were performed as previously described (5) .
Northern and Southern Blot Analyses. Cellular RNA was prepared after extraction with guanidinium isothiocyanate (27) . 10 gg/lane of RNA was subjected to electrophoresis on 1% agarose/0 .7 % formaldehyde gels at 100 V for 4 h before transfer to nitrocellulose filters . 10 Rg of high molecular weight DNA was digested to completion with the indicated restriction enzymes according to the manufacturer's specifications and was subjected to electrophoresis on 0.8% agarose gels at 25 V for 36 h. Southern transfers, hybridization, and washes were performed as previously described (28, 29) . Sizes of labeled DNA fragments were calculated from a Hind III digest of phage X DNA.
cDNA Cloning and Sequencing. Poly(A)' RNA was isolated by oligo(dT)-cellulose (type 7 ; Pharmacia Fine Chemicals, Piscataway, NJ) chromatography (30) . First and second strand cDNA synthesis, and cloning into phage Xgt10 were performed using kits supplied by Amersham Corp. according to the manufacturer's specifications . cDNA was size selected by chromatography over Sephanyl S-500, superfine (Pharmacia Fine Chemicals) . The cDNA library was screened by phage filter hybridization using the CS probe . DNA purified from individual positive recombinant plaques were digested with Eco RI and Klenow labeled with 7 -[ 32 P]-dATP (New England Nuclear, Boston, MA) . DNA fragments were subcloned into M13Mp9 (31) and sequenced by the dideoxynucleotide chain termination method (32) .
DNA Probes . The Vr l, VY2, VY3, and VY 4 probes, all cloned into the pGEM II vector, were the generous gift of Dr. David Raulet (MIT, Boston, MA) (10) . Vyl is a 500-bp Eco RI-Hind III fragment ; Vy2 is an 800-bp Eco RI-Pst I fragment; VY3 is a 300-bp Eco RI fragment ; and Vy4 is a 1 .2-kb Hind III-Sph I fragment . The Ca probe, generously provided by Drs . Tom McMillen and John Coligan (National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD) is a 500-bp Eco RI fragment derived from a full-length cDNA clone . The Jal probe is a 3' genomic Eco RI-Hind III fragment cloned into pGEM3 . The ,J62 probe is a 2.5-kb Eco RI-Xba I fragment cloned into the same vector. Both probes were kindly provided by Dr. Yueh-hsiu Chien, Stanford University, Stanford, CA (19) .
Cell-mediated Cytolysis Assay. 1-5 x 106 target cells (Con A-induced splenic blasts) were radiolabeled with 5 'NaCrO3 (300 pCi, Amersham Corp.) for 1 h at 37°C. Effector cells were harvested 1-2 d after removal of exogenous rIL-2 after stimulation, washed, resuspended in culture medium, and plated in 96-well U-bottomed microculture plates (Costar, Cambridge, MA) containing 1-2 x 103 radiolabeled target cells at selected E/T ratios. After a 4-h incubation at 37°C, the culture supernatants were harvested using the Titertek supernatant collection system (Skatron Inc., Sterling, VA). The percentage of specific lysis was calculated using the formula: Percent specific lysis = 100 x [(Experimental cpm -spontaneous cpm)/(maximum cpm -spontaneous cpm)]. Experimental cpm represents the "Cr released from target cells incubated with effector cells . Maximum cpm represents the release of radiolabel from target cells in a 0 .05 N solution of HCL . Spontaneous cpm represents the background release of target cells cultured in media in the absence of effector cells .
Results
TCR-y/8 CTL Can Recognize a Relatively Nonpolymorphic MHC-linked Class I Molecule. To identify potential ligands for T cells expressing TCRY/S receptors, we derived an alloreactive T cell line from the peripheral lymph nodes of BALB/c (H-2d) nu/nu mice stimulated with low density B10.BR (H-2k) spleen cells (21) . Phenotypic and biochemical analyses demonstrated that this cell line was CD3 + ,CD4 -,CD8 -and expressed the product of a rearranged TCRC r l gene on its surface (21) . Func-tional analysis of the BALB/c nu/nu-derived T cell line showed that it recognized H-2'-expressing but not H-2d-expressing target cells, as judged by proliferation and cytolysis (21) . When assayed for lymphokine production (Fig . 1) , both H-2-congenic B10.BR and BALB .K stimulator spleen cells (APC) induced the production of IFNy and a lymphokine capable of supporting the proliferation of HT-2 cells. Interestingly, further analysis has shown that these y/S cells produce granulocyte/macrophage colony-stimulating factor but no detectable IL-2 or IL-4 (Cron, R. Q, T F. Gajewski, S. O. Sharrow, F. W. Fitch, L . Matis, J. A. Bluestone, submitted for publication). In contrast, H-2-identical BALB/c and B10.D2 APC did not induce lymphokine production (Fig. 1) . These results were consistent with the conclusion that these TCRy/S CTL recognized an MHC-linked antigen. However, the BALB/c nu/nu anti-B10 .BR TCRy/S CTL line was broadly crossreactive, recognizing a variety of allogeneic MHC target cells including H-2k,b .f.9,, (Fig . 2 A) . Of the panel of targets tested, the only allogeneic target cells not lysed expressed the H-2p haplotype.
Two possibilities could explain the high degree of MHC crossreactivity. First, the CTL line might have been heterogeneous, comprising numerous distinct CTL clones each crossreactive for a limited subset of allogeneic targets. Alternatively, the individual TCR-y/8 cells might recognize a relatively nonpolymorphic antigen expressed on either polymorphic or nonpolymorphic MHC gene products common to many MHC-disparate strains. To distinguish between these two possibilities, CTL clones were isolated from the CTL line by limiting dilution and were examined for TCR expression and specificity. Two representative clones, F4 and G8, were isolated and shown to be CD3+,CD4 -,CD8-based on flow cytofluorometry (FCM) analysis (data not shown) and TCRy/S expressing as shown by immunoprecipitation (Fig . 3 ). The G8 (Fig . 2 B) and F4 (data not shown) clones were examined for cytolysic activity on various allogeneic targets and were found to have the same reactivity pattern as the parental line . Thus, the high degree of crossreactivity of the CTL clone indicated that these TCRy/S cells recognized a relatively nonpolymorphic antigenic determinant.
To evaluate more precisely the nature of the MHC-linked molecule recognized by the TCR-y/8 CTL line and clones, CTL specificity was further analyzed by sev- eral approaches. First, lysis of an H-2k-expressing tumor cell line (R1.1) and its R2-microglobulin-negative (02M-) variant (RLE) was examined (Fig. 4 A) . Although the CTL efficiently lysed the parental class I-expressing cell line, no lysis of the (32M-mutant was observed . These results suggested that the TCRr/S CTL recognize a 02M-associated antigen, most likely a class I MHC molecule . Next, a more detailed analysis of the MHC specificity of the CTL line was performed using target cells derived from recombinant, MHC-congenic inbred mice . Our previous studies localized the target antigen recognized by the TCRy/S CTL to the D, L, Q, or TL regions ofthe MHC (21) . For example, B10.OL (H-2Kd, Dk), but not B10.A (H -2K', Dd), were lysed by the BALB/c nu/nu anti-B10 .BR TCRy/S CTL line. Similar H-213-end reactivity of the CTL was observed on the crossreactive H-26 haplotype (21) . Further analyses, performed in the present studies, demonstrated that the CTL were broadly crossreactive on target cells from recombinant H-2q strains (Fig. 4 B) . Although the CTL line lysed target cells from the B10.Q strain (H-2Kq, D9), it did not lyse either B10.AKM (H-2Kk, D9) or B10.T(6R) (H-2Kq, Dd) targets (Fig. 4 B) . These results implied that either the CTL recognition required the expression of H-29 genes encoded in both the K and D end of the MHC, or that the CTL recognized an MHC-linked molecule other than H-2Kq or H-2Dq. This latter possibility was supported by further analysis using other H-2q recombinant strains, namely B10.MBR (H-2Kb , Dq), B10.QBR (H-2K6, Dq), and B10.SQR (H -2K3 , Dq) (Fig. 4 B; reference 33 ). The CTL lysed the B10.QBR but not B10.SQR or B10.MBR target cells. Although all of the strains are H-213q, the TL genes of these mice are of different origins (33) . Specifically, whereas the B10.Q and B10.QBR haplotypes express TLaa (derived from the DBA/1 strain), the B10 .AKM, B10.SQR, and B10.MBR express TLac (derived from an outbred mouse) . Thus the data indicate that these CTL may recognize an MHC class I molecule encoded in the TL region of the TLaa phenotype. This conclusion was supported by the finding that several anti-H-213 and Qregion-specific mAbs did not inhibit CTL activity (data not shown) . In addition, B10.M (H-2r) cells are lysed by the CTL. This result was of interest in view ofrecent studies by Flaherty et al. (33a) , who have shown that in the H-2rhaplotype (B10 .M strain) the QI through Q9 genes have been deleted, including Q7, which is thought to encode the Qa-2 gene product. Thus, it would appear that the BALB/c nu/nu anti-B10 .BR CTL line does not recognize a Qregion-encoded gene product. Finally, an H-2d haplotype pre-B cell line (R8.15) transfected with the H-2D' gene was not lysed by the H-2'-specific BALB/c CTL (data not shown) .
Biochemical Analysis of the 7L'R Expression on the MHC Antigen-speck TCR-y/3 CTL.
Detailed biochemical and molecular analyses of the TCR proteins expressed by these class I MHC antigen-specific TCR-y/8 cells were performed in order to determine similarities or differences between these TCRy/S cells and the predominant TCRy/S populations described in the thymus and peripheral lymphoid organs . Initial biochemical analysis of the G8 cells suggested that the same predominant disulfidelinked TCR proteins were expressed on the clones and parental CTL line as on bulk TCRy/S thymocytes (3, 7) (Fig . 3 A) . To determine which molecular weight species represented the individual TCRy and TCRS proteins expressed on the G8 clone, the TCR proteins were immunoprecipitated with specific antiTCR antisera after dissociating the chains by reduction and alkylation . As shown in Fig. 3 Molecular Analysis of the 7LR Proteins Expressed on the MHC Antigen-speck TCR-y/3 CTL. Although initial N-linked glycosylation analysis suggested that the TCRy protein expressed on the BALB/c alloreactive TCRy/S cells was derived from a rearranged Vy-Cyl, the precise Vy gene expressed could not be assigned because Vy2, Vy3, and Vy4 have all been shown to rearrange to the Cy1 gene (10) . To address this question, molecular analyses of TCR-y genes expressed in the alloreactive TCRy/S CTL were performed. Previously published Southern blot analysis of Eco RI-digested genomic DNA (10) have shown two predominant TCRy rearrangements using a y constant region probe specific for Cy l/Cy2/Cy3. A 16-kb rearranged fragment results from joining of the V10. 8A (Vy 1.2) segment to the Jy2 segment, encoding a Vy1.2-C10.5 (C),2) protein, while a 17kb band represents a Vy2 gene rearrangement (Vy2-C13.4 (Cyl)) (10) . Fig. 5 illustrates a Southern blot analysis of Eco RI-digested genomic DNA from BALB/c liver and the alloreactive TCR-'Y/8 CTL using Vy DNA probes . Upon Eco RI digestion of germline BALB/c liver DNA, two restriction fragments of 5.7 kb and 10 .8 kb hybridize to the Vyl probe, a 5.2-kb fragment hybridizes to the Vy2 probe, and 7-kb bands hybridize to the Vy3 and Vy4 probes (Fig. 5) . Both the Vy3 and Vy4 genes remain in the germline configuration in the BALB/c TCRy/S line and the F4 clone. In contrast, both the Vyl and Vy2 genes have rearranged in the CTL line and clones .
In addition, both Vyl and Vy2 were expressed as full-length TCRy mRNAs in the BALB/c nu/nu line and the G8 line (Fig. 6) . However, V y2-Cy1 but not Vyl.2-Cy2 encodes a glycosylated protein (34) . Thus, from the combined biochemical and mo- Southern Blot analysis of TCR-y rearrangements in the TCR-y/8 BALB/c nu/nu anti-B10.BR alloreactive T cell line and the F4 clone. Eco RI-digested DNA from liver (germline) and the T cell line and clone were hybridized to each of the four probes shown. Performance of the Southern analysis and the origin of the probes are described in Materials and Methods. The sizes of the hybridizing bands are shown (kb) . lecular biologic analyses, it can be concluded that the alloreactive BALB/c nu/nu line and clones express the TCR-y protein product of a Vy2-Cyl gene.
Analysis of 7UR-6 Gene Expression . TCR8 mRNA expression in the MHC-specific line was confirmed using a C8 probe (Fig. 6) . Messenger RNA species of 2.0 and 1 .6 kb were obeserved in the BALB/c nu/nu anti-B10 .BR TCRy/S cells, consistent with previous reports (17) . Moreover, truncated but not full-length TCRa and TCR0 mRNAs were expressed (Fig. 6) , which confirmed the exclusive expression of TCRy/S in these cells. In contrast, no TCRS mRNA could be detected in a TCR-a/R expressing spleen cell population .
TCR-S rearrangements in the alloreactive line and the G8 clone were next examined with two Js probes (19) capable of detecting rearrangements to either of the twoJ$ gene segments, Js1 orj,52, that have been identified (Fig. 7) . Two predominant rearranged bands of 6.2 and 4.8 kb were observed after hybridization of Eco RI-digested DNA from the BALB/c line and G8 clone to the 3''5l probe. For comparison, TCR-8 rearrangements were also examined in bulk TCR-y/8 spleen cells, a BALB/c spleen-derived CD3+,CD4-,CD8-T cell population propagated in vitro FIGURE 6. Analysis of TCR gene expression in TCR-y/S alloreactive T cells. RNA was prepared from the T cell population shown and was examined for the expression of the indicated TCR genes. The origin of the probes and the performance of the Northern analysis is described in Materials and Methods. The sizes of the RNA species were determined by using 5.1 kb and 2.0 kb for ribosomal 28S and 18S as markers. Equalloading of the RNA per lane was determined by ethidium staining of the gels. Lane A represents RNA from a cytochrome c-specific TCR-a/9 Th cell, FLA2 . Lane D represents RNA from whole B10 spleen cells cultured with anti-CD3 as described in Materials and Methods. Lanes B and E represent RNA from the BALB/c nu/nu anti-B10 .BR TCRy/S CTL line, while lanes C and F represent RNA from the TCR-y/8 clones F4 and U8, respectively. for 1 wk by nonspecific stimulation with the anti-CD3 mAb 145-2011, as described in the experimental procedures section (5) . At least four j,51 rearranged bands, including a predominant one of 7.4 kb, were observed in the bulk TCR'Y/8 cells. The 6.2-kb rearrangement ofthe alloreactive CTL but not the 4.8-kb rearrangement was also detected in the unselected TCR-y/8 T cells. Analysis of the Ja2 locus failed to detect any rearrangements in either the alloreactive CTL or the bulk TCRy/8 T cells, consistent with the prior observation (19) that rearrangements to theJa2 segment are far less frequent than to j,51.
To characterize the 7L'R-6 gene, a cDNA library was constructed in phage %gt10 from the BALB/c nu/nu anti-1310.131k T cell line, and TCR-S cDNA clones were iso-FIGURE 7. Southern Blot analysis of TCR-6 rearrangements in the BALB/c anti-B10 .BR alloreactive TCR-,y/8 line. DNA from BALB/c liver, the BALB/c nu/nu anti-B10 .BR TCR-y/8-expressing T cell line, the G8 clone, and a CD3',CD4 -, CD8-BALB/c splenic T cell population propagated in vitro for 1 wk by stimulation with the anti-CD3 mAb was digested with Eco RI (top) or HINDIII (bottom) and hybridized to the 3J61 andJ82 probes, respectively. Southern analysis was performed as described in Materials and Methods. The sizes of the hybridizing bands are shown (kb) . lated using the CS probe. Eco RI digestion of purified phage DNA from colonies containing putative TCR-8 inserts produced several recombinants consisting of a 0.9-kb fragment (the size of the cDNA fragment encoded by the CS gene downstream of its internal Eco RI site and 3' untranslated sequence) (17) as well as one or more additional smaller fragments. Several of the fragments, most likely to contain both C6 and variable gene elements, were subcloned and sequenced . The sequence of a representative 369-bp fragment, 6G8, is shown in Fig. 8 . The clone encodes 5' CS sequence virtually identical to that previously published (17), followed upstream byJS1, DS2, and DSl. Assignments ofj81, DSl, and DS2 are based upon the published germline sequences (19, 20) . N region nucleotides are present between D62 andJSl, and between the V segment and DSl. The inclusion of both D81 and DS2 gene segments is analagous to that observed in previously described TCR-8 cDNA clones derived from adult but not fetal thymocyte populations (19, 20) . The putative V6 gene segment was distinct from any previously published unique VS sequences derived from fetal or adult thymocytes cDNA clones (17, 19, 20) , but was found to be >95% homologous at the DNA level to a previously reported Va gene segment designated Vall .l (35) . The identity of V6G8 with the Va gene family was also supported by the fact that the 5' end of the subcloned 6 fragment represented the exact "I E'= 04 w V y "n ,-= c-S site of an internal Eco RI site within the published hall.l sequence (35) . Moreover, a Vall.l Vsegment probe derived from an antigen-specific TCRa/R-expressing T cell clone (28) hybridized to a 2 .0-kb mRNA in both the BALB/c nu/nu line and the G8 clone (Fig. 6 ) and to the J81-hybridizing 4.8-kb rearranged band (Fig. 7) . Generation of a Distinct MHC-speck TCR-ylS-expressing CTL Line . The apparent TL-linked specificity and high degree of cross-reactivity of the BALB/c nu/nu antiBl0.BR TCRy/8 cell line appeared to contrast with the majority ofTCR-a/R-expressing CTL previously described (36) . In order to further explore the repertoire of TCR-y/6-bearing T cells, studies were undertaken to generate additional MHC-specific TCR-y/8 cells. Lymph node cells from C57BL/10 (1310) nulnu mice, primed in vivo with allogeneic B10.BR spleen cells, were restimulated in vitro as previously described (21) . After 7 wk ofculture the resulting cell line was analyzed for cell surface phenotype, antigen specificity and TCR expression . First, the B10 nu/nu anti-B10.BR line was shown to be CD3~,CD4-,CD8 -(data not shown) and cytolytic. The antigen specificity was therefore examined in cytolytic assays . As was previously observed for the BALB/c TCR-y/8 CTL line, the B10 nu/nu CTL line was specific for an antigen localized to the D, L, Qa, or TLa regions of the MHC (Fig.  9 ). For example, the H-2'-specific CTL lysed B10.BR (H-2Kk, Dk) and C3H.KBR (H-2K', D k ), but not 1310 (H-2Kb, Db) or B10.A(4R) (H-2Kk, Db) target cells. However, in contrast to the BALB/c nu/nu TCRy/8 CTL line, the antigenic determinant recognized by the B10 nu/nu TCR-, y/8 CTL was not expressed on allogeneic target cells and did not map to the H-2TL gene loci. The CTL lysed C3H.KBR (H2Kb,Dk,Qk,TLk) but not B6.K1 (H-2Kb,Db,Q`,TLk). Therefore, the lytic activity of this CTL line maps to the H-2D' locus, a specificity classically observed for TCRa/(3 CTL.
The TCR complex expressed on this line was examined by two-dimensional nonreduced/reduced SDS-PAGE of radiolabeled immunoprecipitates (Fig. 10) . Anti-CD3 mAb (top paneo immunoprecipitated a disulfide-linked TCR dimer (nonreduced mol wt 90 x 103 , reduced mol wt 45-47 x 103) distinct from the TCRy/8 proteins expressed by the BALB/c TCR-y/8 CTL line and distinct from TCR-a/0 proteins expressed by B10 spleen cells (data not shown) . We have recently identified T cells Detailed characterization of the TCR y/S protein expressed on the B10 nu/nu anti-B10 .BR CTL. Anti-CD3 mAb (top) and anti TCRCy4 antiserum (bottom) was used to immunoprecipitate radiolabeled CTL. The immunoprecipitates were analyzed by two-dimensional (nonreducing conditions along the horizontal dimension and reducing conditions along the vertical dimension) offdiagonal PAGE gels . Molecular weights are noted as dots on the figure. in the periphery of normal B10 mice that express a TCR complex consisting of a TCRS chain disulfide-linked to the product of the 7L'R-Cy4 gene (5) . Our studies using an antiserum developed against a peptide corresponding to the COOH-terminal region of the predicted Cy4 gene product (37) precipitated at least two heterodimeric structures, one of which migrated at a molecular weight similar to the B10 anti-B10 .BR line. Therefore, lysate of radiolabeled B10 anti-B10 .BR CTL was immunoprecipitated with the anti-C y4 antiserum. As seen in the lower panel (Fig . 10) , the antiserum immunoprecipitated the same TCR proteins as the anti-CD3 antibody (upper paneo, consistent with the conclusion that this cell line expresses a TCR-y/8 heterodimer and that the TCRy chain is encoded by a rearranged Vy/Cy4 gene .
Discussion
The identification of T cells that express TCRy/S proteins has led to an active interest in determining the specificity, repertoire, and physiologic function of this novel T cell subset . Initial studies demonstrated that TCRy/S T cells, isolated from peripheral T cell populations and activated with an array of antigen-independent stimuli such as mitogens or mAbs, develop non-MHC-restricted cytolytic activity (38, 39) . For instance, CD4-,CD8 -human T cell clones activated with Con A, IL-2, and allogeneic spleen cells lyse a variety of tumor targets including NK-sensitive targets (38) . Thus, it has been suggested that the lymphokine-activated killer activity reported in activated peripheral lymphocytes may, in part, be mediated by T cells expressing the TCRy/S receptor (40) . It has also been suggested that TCRy/S T cells recognize tumor antigens and function in vivo in tumor surveillance (39) by recognizing non-MHC-restricted tumor target antigens . In fact, in some instances, the non-MHC-restricted lytic activity was inhibited by anti-CD3 or antiTCR antibodies (38, 40) . However, recent studies in our laboratory and others (41) have raised questions as to the role of the TCRy/S receptor in mediating this activity. Therefore, our efforts have focused on generating antigen-specific TCR-y/8 cells.
As an approach to identifying the ligand(s) and exploring the repertoire for T cells expressing TCRy/8, we have established alloreactive T cell lines and clones from the peripheral lymph nodes of athymic nu/nu mice stimulated with allogeneic spleen cells. Two independent T cell lines have been described in this report . Both CTL lines have the CD3+,CD4-,CD8 -phenotype, express a TCRy/8 receptor, and recognize an MHC-linked class I antigen. However, the specificity and the receptor usage of the two CTL populations are distinct . One CTL line, and the clones derived from that line, expressed a TCR complex composed of the product of a rearranged Vy2/Cy l gene associated with a TCR8 protein encoded by a well-characterized Va gene segment, Vall, rearranged to both the Das and theJ61 variable gene elements. Functional analysis of the BALB/c nu/nu T cell line showed that it recognized a relatively nonpolymorphic MHC-linked class I molecule mapping within or to the right of the TL region ofthe MHC complex. Based on these initial results, it is interesting to speculate that the TCRy/8 cells have evolved to recognize a distinct subset of MHC antigens encoded by the H-2Q and H-2TL regions. In fact, the abundance of TCRy/8 cells in the epithelia of the skin may provide a unique role for these cells in the recognition of certain infectious agents presented in the context of non-MHC K, D, or L gene products or modified class I antigens. The TL or Qregion-encoded class I antigens may be preferentially expressed on peripheral APC located in epithelia enriched for TCRy/8 cells. Alternatively, the presence of both TL antigens and TCRy/8-expressing T cells early in thymus ontogeny may suggest a role for these antigens in thymic education of TCRy/8 or TCRa/R cells . The fact that the MHC antigens that may be recognized (TLa or Qa) are less polymorphic may also explain the apparently limited Vy and Va gene usage observed in the whole TCRy/8 population (10 ; Fig. 6 ). However, the demonstration of classical H-2Dk-specific class I MHC alloreactivity in the second y/8 receptor expressing T cell line we have described suggests a potentially more diverse repertoire.
Sequence data available from the limited number of MR-6 genes studied to date has revealed several that use known Va segments rearranged to Da andJa elements, although the majority appear to express a unique subset of Va genes (19, 20) . The expression of a Va gene segment by our MHC-specific y/8 receptor-bearing T cells may have implications for the repertoire of these cells. Although the TG'R-y locus has limited germline diversity, the potential for extensive diversity of TCR8 has already been suggested by the observation that the majority of full-length 8 cDNAs derived from an adult thymocyte cDNA library encode sequences from both Dal and Da2 gene segments, allowing for the addition of N region nucleotides at the three distinct junctions (V-1381, Dsl-1382, and D82 Js). The expression of Va genes in y/8 receptors could further amplify their potential diversity. In fact, if additional analysis indicates that the entire germline Va repertoire can participate in the formulation of functional TCR-8 genes, then the potential diversity of the TCR-y/8 may be much greater than originally proposed based upon the limited TCR-y germline repertoire and the apparent limited diversity of the expressed y/8 receptors observed in unselected thymocyte and peripheral CD3+,CD4 -,CD8-T cell populations (10). These observations may be particularly pertinent in light of recent studies with TCR R transgenic mice (42) . These mice express only the TCRR protein encoded by the transgene (endogenous 7CR-,O genes are incompletely rearranged) in association with a heterogeneous host-encoded TCR-a repertoire, and are nevertheless reported to manifest normal allogeneic responses. The TCR-y/S repertoire has the potential to be at least as diverse as the TCR-a/(3 repertoire of such transgenic animals. Moreover, the expression of a Va gene in the first MHC antigen-specific TCR-, y/8-bearing T cell invites speculation that this association may not be fortuitous. One striking difference between most Va genes and the unique Va gene segments thus far isolated appears to be that unlike most Va genes, Va genes represent single copy families (20) . Perhaps TCRy/S that express the unique Vs segments recognize a distinct set of antigens and those TCR expressing Va gene elements will comprise the majority of TCRy/S cells with MHC-linked specificity.
Interestingly, the Va11 gene segment of8G8 has been previously shown to be the predominant TCR-a gene expressed in a class II MHC-restricted antigen response (28, 35, 43) . Thus, it is possible that TCRy/S receptors have the potential to recognize a broad range of MHC-encoded ligands. We have shown here that whereas the BALB/c anti-B10 .BR T cell clones appear to recognize a nonconventional class I MHC antigen encoded within the TL region, the B10 nu/nu anti-BlO .BR y/S T cell line recognizes a conventional class I MHC molecule encoded within the H-2D' subregion. It may be that additional TCR-y/S T cells will recognize class II MHC molecules as well as a variety of non-MHC peptides in an MHC-restricted fashion, analogous to TCRa/o. Analysis of additional MHC-specific TCR-y/Sexpressing T cell lines and clones is in progress to address these questions. 
Summary

